Sodium Valproate Monitoring

This report aims to identify the number of female patients of child bearing age that have received prescriptions from their GP for sodium valproate. This data will be produced every 6 months to contribute to the monitoring of effectiveness of actions to ensure safe and appropriate use of sodium valproate in Northern Ireland. 

For more information on why this is important, particularly if you are female and taking sodium valproate, view the toolkit on the risks of valproate medicines in female patients.

Latest Version

 Sodium Valproate Monitoring Report up to December 2020